Dr. Anderson is Professor at Harvard Medical School, an adjunct Professor at MIT, and Director of the Wellman
Center for Photomedicine at Massachusetts General Hospital in Boston, the world's largest academic facility
dedicated to the use of light for diagnosis and therapy. He conceived and developed dermatologic surgery
using selectively-absorbed laser pulses, which is now the preferred basis for treatment of birthmarks,
pigmented lesions, tattoos, hypertrichosis and other conditions. Active research includes diagnostic tissue
imaging and spectroscopy, photodynamic therapy, mechanisms of laser-tissue interactions, and novel therapy
for skin disorders. Dr. Anderson received his undergraduate degree from MIT and his M.D. from Harvard
Medical School through the MIT-Harvard Health Sciences and Technology program.
Dr. Lahann is Dow Corning Associate Professor of Chemical Engineering at the University of Michigan. His research explores the scientific interface between materials chemistry and biotechnology. His work resulted in key materials technologies including reversibly switching surfaces (Science 2003), anisotropic nanocolloids (Nature Materials 2005), and multifunctional nanocoatings (JACS 2006, PNAS 2007). Dr. Lahann has been selected by Technology Review as one of the top young innovators (TR35) and is also the recipient of the 2007 AICHE Nanoscale Science and Engineering Award, a NSF-CAREER award, and a DOD Idea award. Dr. Lahann has published over 70 papers and contributed to more than 20 patents and patent applications. Dr. Lahann received his M.S. and Ph.D. in macromolecular chemistry from RWTH Aachen.
Dr. Langer is one of 13 Institute Professors at MIT. His research interests are in the areas of biomaterials, drug delivery, and bioengineering. A member of the Institute of Medicine, National Academy of Engineering and National Academy of Sciences, Dr. Langer has received over 170 major awards, has written over 1050 articles, and has over 700 issued or pending patents worldwide. In 2007, he was awarded the National Medal of Science, the highest civilian honor bestowed by the United States. As many as 20 companies were launched on the basis of his patent licenses, including Momenta Pharmaceuticals, Advanced Inhalation Research (AIR), Transform Pharmaceuticals, BIND Biosciences, and Selecta Biosciences. Dr. Langer received his B.S. from Cornell University, and his Sc.D. from MIT, both in chemical engineering.
Dr. Mitragotri is Professor in the Department of Chemical Engineering at the University of California, Santa Barbara. His research interests are in novel methods of drug delivery. Dr. Mitragotri has published over 80 peer reviewed journal articles; he is an editor of several journals in the field of drug delivery and a co-inventor in over 30 issued and pending patents. He has received numerous awards for his work, including the Technology Review Young Innovator award and distinctions from the Controlled Release Society, the American Pharmaceutical Association, and the American Institute of Chemical Engineers. Dr. Mitragoti received his M.S. and Ph.D. in chemical engineering from MIT.
Dr. Prausnitz's research interests focus on biophysical methods of drug delivery employing microfabricated devices, microneedles and other physical means to control the transport of agents into and within the body. He has been the founder of three start-up companies in the area of microneedles, has published more than 175 research articles, and has filed 35 issued or pending patents. Dr. Prausnitz earned a B.S. from Stanford and a Ph.D. from MIT, both in chemical engineering. He worked at Alza Corporation conducting transdermal drug delivery research systems, and at ORBIS International teaching biomedical engineering in developing country hospitals.
Dr. Walt is Robinson Professor of Chemistry at Tufts University and a Howard Hughes Medical Institute Professor. He is a member of the National Academy of Engineering, has published over 200 peer reviewed journal articles, and has over 50 issued and pending patents. He is also a Founding Scientist, Director and Chairman of the Scientific Advisory Board at Illumina, Inc. and Quanterix Corporation. His current research focuses on applying micro and nanotechnology to problems such as the analysis of genetic variation and the behavior of single cells, as well as the practical application of arrays to the detection of explosives, chemical warfare agents, and food and waterborne pathogens. Dr. Walt received his B.S. in Chemistry from the University of Michigan and his Ph.D. from SUNY at Stony Brook in Chemical Biology.